Detalles de la búsqueda
1.
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities.
Rev Endocr Metab Disord;
25(1): 187-202, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715050
2.
Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.
BMC Cancer;
23(1): 1209, 2023 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38066522
3.
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids.
Int J Mol Sci;
24(13)2023 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37446353
4.
Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective study.
Support Care Cancer;
30(8): 6583-6591, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484315
5.
Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma?
Anticancer Drugs;
29(4): 287-294, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29420335
6.
Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey.
Oncology;
93(1): 11-17, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28423384
7.
Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor.
Acta Oncol;
55(3): 329-40, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26494607
8.
Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial.
Radiother Oncol;
197: 110329, 2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768714
9.
Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction.
Cells;
12(5)2023 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36899869
10.
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer.
Front Immunol;
14: 1264093, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38022675
11.
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
Front Oncol;
11: 714551, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778031
12.
Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma.
Cancers (Basel);
13(12)2021 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34207120
13.
Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Cancers (Basel);
12(9)2020 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32967162
14.
Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report.
J Med Case Rep;
13(1): 202, 2019 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31248444
15.
Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
Chin Clin Oncol;
7(6): 60, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30180748
16.
Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer.
Oncotarget;
9(101): 37581-37588, 2018 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30680071
17.
First report of trastuzumab treatment after postoperative Takotsubo cardiomyopathy.
Anticancer Res;
34(7): 3579-82, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24982372
Resultados
1 -
17
de 17
1
Próxima >
>>